Sei Investments Co. Lowers Stake in Amedisys, Inc. (NASDAQ:AMED)

Sei Investments Co. lowered its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 50.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,549 shares of the health services provider's stock after selling 3,636 shares during the period. Sei Investments Co.'s holdings in Amedisys were worth $322,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Blue Trust Inc. increased its position in shares of Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after acquiring an additional 124 shares in the last quarter. Xponance Inc. boosted its stake in Amedisys by 3.5% during the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock valued at $395,000 after purchasing an additional 148 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of Amedisys by 3.6% in the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock worth $400,000 after purchasing an additional 155 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Amedisys by 1.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock worth $1,375,000 after purchasing an additional 180 shares during the last quarter. Finally, Retirement Systems of Alabama lifted its holdings in shares of Amedisys by 0.5% during the fourth quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider's stock valued at $3,615,000 after purchasing an additional 181 shares in the last quarter. Institutional investors own 94.36% of the company's stock.

Remove Ads

Amedisys Price Performance

Shares of NASDAQ:AMED traded down $0.07 during midday trading on Monday, reaching $91.44. 274,062 shares of the company were exchanged, compared to its average volume of 401,430. The stock has a market cap of $3.00 billion, a PE ratio of 36.29, a price-to-earnings-growth ratio of 1.78 and a beta of 0.89. The business's fifty day moving average is $92.20 and its two-hundred day moving average is $92.01. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $598.05 million for the quarter, compared to analysts' expectations of $602.38 million. As a group, analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Stephens reiterated an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research note on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $101.00.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.